Pembrolizumab: The nut cracker

Selvarajan, G

INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2020; 41 (3): 393

Abstract

Anti-programmed cell death-1 (PD-1)/PD ligand-1 immune checkpoint inhibitors (ICIs) are the newest class of drugs approved for various advanced cancer......

Full Text Link